These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28368997)

  • 61. Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.
    Loftus J; Christopoulou D; Blak BT; Hards M
    Eur J Ophthalmol; 2012; 22(3):376-87. PubMed ID: 22034021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma.
    Siesky B; Harris A; Ehrlich R; Cantor L; Shoja MM; Rusia D; Hollander DA; Abrams L; Williams JM; Shoshani Y
    Adv Ther; 2012 Jan; 29(1):53-63. PubMed ID: 22246943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
    Spaeth GL; Bernstein P; Caprioli J; Schiffman RM
    Am J Ophthalmol; 2011 Jan; 151(1):93-99.e4. PubMed ID: 21111399
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
    Goldberg LD; Walt J
    Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost.
    Cheng JW; Li Y; Wei RL
    Ophthalmic Res; 2009; 42(2):99-105. PubMed ID: 19546601
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ocular hypotensive effects of anti-glaucoma agents in mice.
    Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):401-8. PubMed ID: 19857101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
    Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
    Adv Ther; 2014 Jun; 31(6):592-603. PubMed ID: 24919410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities.
    Ocansey S; Kyei S; Diafo A; Darfor KN; Boadi-Kusi SB; Aglobitse PB
    BMC Health Serv Res; 2016 Jul; 16():282. PubMed ID: 27430262
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.
    Goñi FJ;
    Eur J Ophthalmol; 2005; 15(5):581-90. PubMed ID: 16167288
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
    Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E;
    Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F; Ermis SS; Inan UU
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP).
    Atkinson MJ; Stewart WC; Fain JM; Stewart JA; Dhawan R; Mozaffari E; Lohs J
    Health Qual Life Outcomes; 2003 Nov; 1():67. PubMed ID: 14617372
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
    Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):955-66. PubMed ID: 23285843
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan.
    Chang PY; Wang JY; Chang SW; Chang YC
    J Glaucoma; 2018 Jul; 27(7):600-605. PubMed ID: 29757810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ophthalmologist and Optometrist Glaucoma Prescribing Patterns Based on 2015 Medicare Part D Data.
    Priluck AZ; Dietze J
    Ophthalmol Glaucoma; 2019; 2(1):63-66. PubMed ID: 32672560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker' health study (Spain).
    Aguilar-Palacio I; Malo S; Lallana M; Feja C; González J; Moreno-Franco B; Rabanaque M
    BMJ Open; 2019 Apr; 9(4):e023571. PubMed ID: 30987984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.